logo-loader

Adaptimmune Therapeutics PLC

Receive alerts
Market:
NASDAQ
Market Cap:
$422.77 m
Price
4.02 USD
Change
0.50%
52 weeks high
6.00
52 weeks low
0.71

In brief

Adaptimmune is a clinical-stage biopharmaceutical company focused on the development of novel cancer immunotherapy products for cancer patients.